Public campaigns encouraging sun protection for skin cancer prevention began in Queensland, Australia, in the early 1980s. We examined recent trends to assess whether earlier evidence of stabilizing melanoma incidence in young people has persisted. Anonymized incidence and mortality data for in situ and invasive melanoma for the 20 years 1995-2014 were obtained from the Queensland Cancer Registry. Time trends were analyzed using JoinPoint regression. Birth cohort patterns were assessed using age-period-cohort models. Melanoma incidence in Queensland remains the highest recorded in the world (age-standardized incidence of invasive melanoma (2010-2014) 5 72/100,000/annum). Over the 20-year period, incidence of in situ melanoma increased in all age groups. Incidence of both thin (1 mm) and thick (>1 mm) invasive melanoma was either stable or decreased in people under 60, while it increased in those aged 60 and above, particularly in men. Ageperiod-cohort analysis revealed decreasing age-specific incidence of invasive melanoma under 40 years of age, beginning with the birth cohort born around the mid-1960s, with steepest falls for those born around 1980 and later. Age-specific incidence was stable between 40 and 59 years of age from the 1945 birth cohort onwards. Melanoma mortality over the period was stable or decreased in all groups except in men aged 60 or over. These findings are evidence of real advances in the prevention and early detection of invasive melanoma in this very high-risk population. They make a compelling case for continued public health efforts to reduce the burden of melanoma in susceptible populations.
Introduction
Queensland, the second-largest Australian state, has long had the highest recorded melanoma incidence in the world 1 due to the combination of a largely white-skinned population, high ambient UV radiation and an outdoor lifestyle. 2 Public education to encourage awareness of the importance of early diagnosis of melanoma began in Queensland in the early 1960s in what was one of the first such campaigns in the world. 3 When solar radiation came to be understood as the main cause of skin cancer, [4] [5] [6] these campaigns were expanded to encompass prevention through protection from sun exposure. The "Slip (on a shirt), Slop (on sunscreen), Slap (on a hat)" skin cancer prevention campaign in the early 1980s, replaced by the national SunSmart campaign in the early 1990s, received wide coverage 7 and resulted in broad community awareness of both the risk of skin cancer and the importance of sun protection in Australia's sunny climate, including in subtropical Queensland. 8 Prevention campaigns for skin cancer continue in Queensland and other states, with a strong focus on the childhood years, including the long-running SunSmart Schools Program that encourages a range of activities including school uniforms that meet sun protection standards and a "No Hat, No Play" policy for outdoor activities.
The most recent examination of trends in melanoma incidence and mortality across the Queensland population examined the 21-year period . 10 The authors drew two conclusions: first, that despite an increase in overall incidence during the period, mortality had remained stable, presumed to be due in large part to earlier diagnosis and, second, that incidence rates appeared to have stabilized in those under 35 years. This last point is particularly relevant given that melanoma is the most common type of cancer (excluding keratinocyte cancers) diagnosed among Australians aged 15-34, estimated to account for 20% of all cancer diagnoses and 9% of all cancer-related deaths in this age group between 2009 and 2013. 11 We examined trends in melanoma incidence and mortality over the most recent 20-year period for which data are available (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) to assess whether the earlier reported patterns of stabilizing mortality and, in younger people, stabilizing incidence, have been sustained.
Methods

Data
De-identified information was extracted from the Queensland Cancer Registry for each patient diagnosed with a first primary invasive or in situ melanoma (ICD-O-3 code "C44," morphology code 8720-8790) between 1995 and 2014 inclusive. Data quality was high, with 98.9% of cases in the study being histologically verified and <0.1% registered on the basis of death certificate only.
In the previous incidence study, 10 cases of lentigo maligna (morphology code 87422) were excluded because of concerns about consistency of identification and lack of histopathologic diagnosis. The introduction of techniques such as dermoscopy and associated training have improved diagnostic accuracy and pathologic reporting of skin cancers 12, 13 and so to provide a more complete picture, lentigo maligna cases were included in the present analysis. To allow direct comparison to the previous results, 10 trend analyses were repeated after excluding cases of lentigo maligna. For persons with multiple primary invasive melanomas diagnosed during the study period, only the first diagnosis was included. If both an invasive and an in situ melanoma were recorded for the same person, only the invasive melanoma was counted even if it was diagnosed subsequent to the in situ tumor, consistent with the approach used by Coory et al.
10
Data items available included sex, age at diagnosis, year of diagnosis, tumor thickness (categorized as thin (1 mm) or thick (>1 mm)) and, where applicable, age, year and cause of death. Mortality was confirmed via record linkage between the Queensland Cancer Registry, the Queensland Register of Births, Deaths and Marriages and the National Death Index.
Statistical analysis
Incidence trends were analyzed separately for in situ and invasive melanomas, according to sex, broad age group (0-39, 40-59 and 601 years old), and thickness (invasive only). Mortality trends were analyzed by sex and broad age group. Annual rates were directly age-standardized to the 2001 Australian Standard Population, 14 and JoinPoint regression software (National Cancer Institute, Rockville, Maryland) was used to fit trend lines. The joinpoint method starts with the assumption of a constant trend (no joinpoint) over the entire study period and then uses Monte Carlo permutation tests to determine any significant changes to the direction or magnitude of the trend. 15 The selected model is the one with the fewest joinpoints that provides the best fit to the observed data. For our study, a maximum of two joinpoints was specified for each model with a minimum of 5 years between joinpoints or between a joinpoint and either end of the time series. Trends were expressed in terms of the annual percentage change and 95% confidence interval (95% CI). Statistical significance (p <0.05) was determined using a two-sided ttest. Patterns of age-specific incidence rates by birth cohort were assessed separately for in situ and invasive melanomas by fitting age-period-cohort models. Overlapping 10-year birth cohorts were defined with mid-years 1915, 1925 and so on up to 1995, based on period of diagnosis (5-year calendar periods from 1995-1999 to 2010-2014) and 5-year age groups (from 15-19 to 85-89 years). The age-period-cohort model was fitted using Poisson regression, with incidence counts as the outcome variable, birth cohort, age group and calendar period as covariates and the log of the respective population count as an offset variable. We used the method described by Jemal et al. 16 to evaluate the change in the slope (C) for the age-specific incidence trends for each birth cohort between 1930 and 1980. This What's new? Queensland, Australia has long had the highest recorded melanoma incidence in the world, with public campaigns encouraging sun protection for skin cancer prevention beginning in the early 1980s. Here, the authors examined recent trends to assess whether earlier evidence of stabilizing melanoma incidence in young people has persisted. They show that rates of invasive melanoma have peaked over the last two decades for persons aged under 60. Coupled with stable or declining mortality rates, except in men over 60, the results provide substantive evidence that long-running melanoma prevention and early-detection campaigns have reduced the burden of melanoma across successive generations.
change in slope for a birth cohort j represents the difference between the later birth cohorts (j to j13) compared to the earlier birth cohorts (j23 to j). A negative value indicates that the age-specific incidence trend slope for birth cohorts coming after birth cohort j has decreased compared to earlier birth cohorts, specifically, if an increasing trend begins to decelerate or fall.
Results
A total of 97,114 eligible cases of melanoma diagnosed between 1995 and 2014 were included in the study cohort. Of these, 55% were invasive (n 5 53,029) and 45% were in situ (including lentigo maligna) (n 5 44,085). Within each of the invasive and in situ groups, more cases were male (55% and 58% respectively) and the median age at diagnosis was 60 years. Information on thickness was missing for 7% of invasive melanomas per year on average. Among the remainder, almost three-quarters (73%) were thin (1 mm) at diagnosis.
Broad incidence trends
Invasive melanoma. Over the 20 years 1995-2014, the agestandardized incidence of invasive melanoma increased from 73 to 89/100,000 per annum among males, and from 50 to 59/100,000 per annum among females. For all persons combined, the average age-standardized incidence of invasive melanoma for the most recent 5 years 2010-2014 was 72/ 100,000 per annum. The modeled data showed fluctuating trends in the overall incidence of thin invasive melanomas for both males and females with significant increases from 2006 onwards whereas there were significant increases over the entire study period (1995-2014) for thick invasive melanomas by sex ( Fig. 1 , Table 1 ). Marked differences were observed in the corresponding trends by broad age group. In people under 40 years, there was a uniform and significant decline in incidence of thin melanoma (2.5% decline per year in males, 1.7% in females) over the whole 20-year study period, while the incidence of thick melanoma was stable. Among those aged 40-59 years, incidence was stable over the period, for both thin and thick melanoma. Increasing incidence was seen only in the oldest age-group (601 years), for whom incidence of thin (2.6% per year in both sexes) and thick (2.0% per year in males; 1.1% per year in females) melanoma increased uniformly over the whole period (Table 1) .
In situ melanoma. Over the 20 years 1995-2014, the observed age-standardized incidence of in situ melanoma increased from 31 to 113/100,000 per annum among males, and from 28 to 83/ 100,000 per annum among females. For both sexes combined, the average age-standardized incidence of in situ melanoma for the most recent 5 years 2010-2014 was 82/100,000 per annum. The modeled data showed a steep increase in incidence rates for both sexes throughout the 20-year period, with an average increase of 6.9% per year in males and, for females, 4.0% per year between 1995 and 2006 and 8.5% per year between 2006 and 2014 ( Fig. 1, Table 1 ). Over the last 10 years, rates of in situ melanoma increased uniformly by around 7% per year within each of the three broad age groups (0-39, 40-59, 601 years), except for males under 40 whose annual increase was somewhat lower at 4.5% (Table 1) . Very similar trends were observed when cases of lentigo maligna were excluded from the analysis (results not shown).
Incidence trends by calendar period and birth cohort
The age-period-cohort model provided a significantly better fit to the data than either the age-period model or the agecohort model for both males and females, indicating that the observed incidence trends are influenced independently by both birth cohort and calendar period. For brevity, 10-year birth cohorts are referred to in the following by their midpoint years.
Invasive melanoma. Age-specific incidence generally fell in age groups under 40 years, beginning with the 1965 birth Table 1 .
cohort, particularly among males (Fig. 2) . The rate of decrease in age-specific incidence rates for invasive melanoma was greatest for males and females born around 1980 (Supp Fig. S1 ). Rates stabilized in all 5-year age groups between 40 and 59 years, beginning with the 1945 birth cohort. In contrast, age-specific incidence rates for invasive melanoma in all 5-year age groups from age 60 increased over the 20-year study period; however, there was a marked deceleration in the rates, as shown by the gradual flattening of the birth-cohort slopes, in almost all successive birth cohorts from 1930 onwards ( Fig. 2; Supp Fig. S1 ).
In situ melanoma. There were steep, ongoing increases in the age-specific incidence rates of in situ melanoma in almost all successive birth cohorts for all 5-year age groups from age 25, for both males and females, although the rate of increase 3 Includes in situ lentigo maligna melanoma. 4 Statistically significant trends are shown in bold.
(as measured by the birth cohort slopes) began to slow from about the 1945 birth cohort, particularly among females ( Fig.  2; Supp Fig. S1 ).
Mortality trends
A total of 5,061 deaths due to melanoma were reported for Queensland residents between 1995 and 2014, with about two-thirds of these deaths being males (n 5 3,462, 68%). The median age at death was 70 years for males and 68 for females. Average annual age-standardized mortality due to melanoma was 7/100,000 (11/100,000 for males and 4/ 100,000 for females) between 2010 and 2014. The overall age-standardized melanoma mortality rate was stable for males and females over the study period although, as was the case for incidence of invasive melanoma, the mortality patterns by broad age group were quite distinct ( Fig. 3 and Table 2 ). Melanoma mortality decreased by 3.4% per annum for males under 40 and by 1.8% per annum for males [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] . Mortality also fell in females under 40 (2.9% decrease per annum) while it was stable for females 40 and over. The only group which recorded a significant increase in melanoma mortality was males aged 60 and over, among whom mortality rose by 1.8% per annum in the 20 years from 1995 to 2014.
Discussion
At 72 cases per 100,000 per annum on average, the incidence of invasive melanoma in Queensland remains the highest recorded in the world, substantially more than that of New Zealand, with the next highest recorded incidence (50/ 100,000 for the period 2007-2011 using the 2000 United States Standard Population), and higher than that of Australia as a whole (48/100,000). 17 The melanoma mortality rate in Queensland (7/100,000) is similar to that reported for Australia as a whole (6/100,000 in 2014) 18 but still somewhat higher than in most other parts of the world such as the Nordic countries (collectively 6/100,000 for males and 4/ 100,000 for females in 2014) 19 or the United States (3/ 100,000 during 2010-2014) 20 . Whiteman et al. 17 summarized contemporary public health efforts to prevent melanoma in six populations (US whites, the United Kingdom, Sweden, Norway, Australia and New Zealand). Sun protection promotions in the US and Europe have generally been less coordinated and/or had less population coverage 21, 22 than in Australia and New Zealand, where mass media campaigns have been conducted since the early 1980s. 7 Therefore, it is perhaps not surprising that invasive melanoma incidence rates are projected to continue to rise in these countries in contrast to predicted declines within Australia and New Zealand. 17 Figure 2. Age-specific incidence rates of in situ and invasive melanoma by mid-year of birth cohort, Queensland, 1995-2014. The years of birth on the horizontal axes in Figure 2 indicate the mid-points of overlapping 10-year birth cohorts. The points vertically above each midpoint year show that cohort's age-specific incidence rates (noting the log scale).
We have shown that age-standardized incidence of invasive melanoma in Queensland is continuing to stabilize or decline in those under 40 years, has now stabilized in the 40-59 age group, and continues to increase only in people aged 60 years or over. The much higher incidence rates among older Queenslanders are thus driving the overall increasing age-standardized incidence of invasive melanoma that we observed. An earlier analysis of the period 1982-2002 in Queensland suggested that incidence of invasive melanoma was stabilizing in people under 35 years. 10 With a further 12 years of data to 2014, our findings add weight to this earlier result and confirm that, over time, rates appear to be stabilizing and then falling in progressively older age groups.
This result is echoed in the analysis of incidence trends by birth cohort and calendar period. In the earlier published age-period-cohort analysis, age-specific incidence rates of invasive melanoma were generally increasing from one birth cohort to the next, particularly among males, but the rate of increase had begun to slow and had flattened in people younger than 35 and born around 1958 or later. 10 This pattern has continued and intensified, with age-specific incidence rates of invasive melanoma now actually falling in people younger than 40 and born around 1960 or later, particularly among males. The fall is steepest for those born since the 1980s and this group now has significantly lower melanoma incidence rates than did earlier generations of Queenslanders at the same age.
The evidence presented here is consistent with a birth cohort effect that coincides with the introduction of sun safety campaigns during the last decades of the 20th century, and is seen most strongly in those generations born since the 1980s who have lived with the sun protection message from childhood. 23 Migrant studies have highlighted the importance of early life sun exposure to melanoma incidence in later life. 24, 25 The reduced risk enjoyed by recent birth cohorts in Queensland is likely to persist as these birth cohorts age, potentially resulting in declining age-specific incidence rates in successively older age groups. Moreover, the observation that age-specific melanoma incidence rates are now stabilizing in birth cohorts born as early as 1945 suggests that the benefits of sun protection campaigns have also extended to those who first experienced these campaigns as young adults.
Another possible reason for reduced sun exposure in younger generations is an increase in indoor leisure activities (e.g., television watching, playing video games and using computers). It has been estimated that children in the United States have lost 50% of time spent on unstructured outdoor activities since the 1970s 26 and instead use screen devices for an average of 7 hr per day. 27 This change in lifestyle, Figure 3 . Trends in the mortality rates of invasive melanomas by age at death and sex in Queensland, 1995-2014. Rates were directly age-standardized to the 2001 Australian Standard Population. Trends calculated using JoinPoint regression. y-Axis is shown on a log scale. however, seems less likely to explain the stabilization in malignant melanoma incidence that we observed among the middle-aged cohorts during the study period. It has been proposed that the decreasing incidence of invasive melanoma in young age groups in Queensland could also be explained by the effect of immigration by people with darker skin who are at low melanoma risk. 28 We have previously used a simulation study 29 to demonstrate that melanoma incidence rates among younger Queenslanders are decreasing irrespective of changes in the ethnic mix of the population. This finding held true even under the extreme assumption that the entire population increase within this age group since 1982 was due to immigration from low melanoma risk countries. 29 The results support our assertion that public education campaigns and a changing attitude to sun exposure have played a key role in the observed reduction of melanoma incidence among more recent birth cohorts in Queensland.
The down-turning trends in age-standardized incidence of invasive melanoma among younger people in Queensland are unusual in white populations around the world. A recent examination of trends in 39 countries by Erdmann et al. 30 showed increases in incidence in virtually all Caucasian populations examined, including in people aged under 45. However, in line with our results, the authors pointed to an apparent decline or stabilization in melanoma risk among birth cohorts since the 1950s in New Zealand, Canada and Australia as a whole, for males and females, and noted that this is consistent with a change in generational UV exposure particularly in childhood. [30] [31] [32] Ultimately, a reduction in melanoma mortality is the true measure of success of prevention and early detection campaigns. In Queensland, there has indeed been a significant decline in melanoma mortality rates approaching 2% per annum in males 40-59 years, and an even steeper decline of around 3% per annum in both sexes under 40. This contrasts with males over 60, with melanoma mortality continuing to increase at roughly the same pace (about 2% per annum) as the increase in incidence of thick melanomas among males in this age group. That this increase is occurring beside even steeper increases in in situ lesions in older men suggests that it is not for lack of efforts to improve early diagnosis. New strategies, such as regular skin screening targeted to betterdefined high risk groups, are needed, although earlier detection of rapidly invasive, nodular lesions (comprising about one-third of thick melanomas diagnosed in older men) remains a challenge. 33 As it has done since records began in 1982, in situ melanoma incidence continues to climb in Queensland at a much faster pace than that of invasive melanoma. Rapid annual increases in the incidence of in situ melanoma have been reported in other white-skinned populations including the United States, 34 the Netherlands 35 and Denmark, 36 with rates in the last two increasing at an even faster pace than those in Queensland. These trends are likely explained, at least in part, by improved understanding and awareness, both among clinicians and the public, of the critical importance of early detection and treatment of this disease. Broad concern about skin cancer in the very high-risk Queensland population is manifest in an increasing demand for and availability of skin screening examinations, a rapid growth over recent years in the number of primary care skin cancer clinics, 37, 38 and improved opportunities for clinical training in early diagnosis in primary care. This is perhaps coupled with a heightened level of clinical suspicion, a degree of diagnostic shift and increased potential for histopathologic over-diagnosis.
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The long-term increase in in situ lesions is far outstripping the decrease in melanoma mortality, implying that in a significant proportion of cases, the treatment of in situ melanoma is likely to have had no impact on the patient's longevity. While the excision of innocuous lesions carries a significant cost both to patients and the health system, it is difficult to see the situation changing, given the potentially serious consequences of a missed melanoma and limited understanding and recognition of which atypical melanocytic lesions are benign and which are malignant and at risk of progression.
The main strengths of our study were the very large size of the sample and the use of population-based data comprising all eligible in situ and invasive melanomas registered in Queensland. It should be noted that improvements in the recording of melanoma thickness have resulted in a reduction over time in the proportion of invasive melanoma with unknown thickness, which may have influenced observed trends in thin and thick melanoma in both the previous and present studies. However, this is becoming less of a problem as thickness was only missing for a minority of malignant cases in our data (7%), so while the proportion of melanoma cases with a recorded thickness has improved over time, the influence of this on the observed results is likely to be minimal.
In summary, the results presented here for the period 1995-2014 in Queensland reveal: (1) stable or falling incidence of invasive melanoma in those under 60 years; (2) a birth cohort effect manifested in declining age-specific incidence rates of invasive melanoma starting with those born in the 1960s, with steepest declines among those born in the 1980s or later and (3) stable or declining melanoma mortality rates in all groups except males aged 60 and over. This is strong evidence for real advances in the prevention and early detection of invasive melanoma in this very highrisk population. Nevertheless, Queensland continues to have the highest recorded incidence of melanoma of any population world-wide and there is no room for complacency. These findings, together with recent international evidence, make a compelling case for a continuation and strengthening of public health efforts to reduce the incidence and mortality of melanoma in all susceptible populations around the world.
